HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, S. T. Articles by Sun, X.-H. Search for Related Content PubMed PubMed Citation Articles by Park, S. T. Articles by Sun, X.-H. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 12, 7030-7037, March 20, 1998

The Tal1 Oncoprotein Inhibits E47-mediated Transcription
MECHANISM OF INHIBITION

From the Department of Cell Biology, New York University Medical Center, New York, New York 10016

The Tal1 oncogene is a class II basic helix-loop-helix (bHLH) transcription factor, overexpressed in as much as 60% of T cell acute lymphoblastic leukemia cases. Like other class II bHLH proteins, Tal1 can heterodimerize with the class I bHLH proteins, such as E47, and bind to a DNA recognition sequence termed E box. Therefore, it is believed that the oncogenic capacity of Tal1 lies in its ability, as a heterodimer with E47, to activate aberrantly a set of "leukemogenic" genes in T cells. However, compared with E47 homodimers, Tal1/E47 heterodimers are very poor transactivators. Thus the effect of Tal1 is actually to inhibit E47 homodimer activity. Here we propose that the transforming properties of Tal1 are the result of its ability to inhibit E47 activity. We address the mechanism of Tal1 inhibition and demonstrate that Tal1/E47 heterodimers cannot activate transcription because their respective activation domains are incompatible. Furthermore, we present data showing that Tal1 can inhibit E47-mediated activation of the CIP1 gene. Finally, we demonstrate that Tal1 inhibits E47 activity in leukemic T cells.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				L. Nie, H. Wu, and X.-H. Sun Ubiquitination and Degradation of Tal1/SCL Are Induced by Notch Signaling and Depend on Skp2 and CHIP J. Biol. Chem., January 11, 2008; 283(2): 684 - 692. [Abstract] [Full Text] [PDF]

				S. S. Perry, Y. Zhao, L. Nie, S. W. Cochrane, Z. Huang, and X.-H. Sun Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance Blood, October 1, 2007; 110(7): 2351 - 2360. [Abstract] [Full Text] [PDF]

				T. Palomero, D. T. Odom, J. O'Neil, A. A. Ferrando, A. Margolin, D. S. Neuberg, S. S. Winter, R. S. Larson, W. Li, X. S. Liu, et al. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia Blood, August 1, 2006; 108(3): 986 - 992. [Abstract] [Full Text] [PDF]

				A. H. Schuh, A. J. Tipping, A. J. Clark, I. Hamlett, B. Guyot, F. J. Iborra, P. Rodriguez, J. Strouboulis, T. Enver, P. Vyas, et al. ETO-2 Associates with SCL in Erythroid Cells and Megakaryocytes and Provides Repressor Functions in Erythropoiesis Mol. Cell. Biol., December 1, 2005; 25(23): 10235 - 10250. [Abstract] [Full Text] [PDF]

				P. A. Zweidler-McKay, Y. He, L. Xu, C. G. Rodriguez, F. G. Karnell, A. C. Carpenter, J. C. Aster, D. Allman, and W. S. Pear Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies Blood, December 1, 2005; 106(12): 3898 - 3906. [Abstract] [Full Text] [PDF]

				C. Y. Hong, E.-Y. Gong, K. Kim, J. H. Suh, H.-M. Ko, H. J. Lee, H.-S. Choi, and K. Lee Modulation of the Expression and Transactivation of Androgen Receptor by the Basic Helix-Loop-Helix Transcription Factor Pod-1 through Recruitment of Histone Deacetylase 1 Mol. Endocrinol., September 1, 2005; 19(9): 2245 - 2257. [Abstract] [Full Text] [PDF]

				Z. Huang, L. Nie, M. Xu, and X.-H. Sun Notch-Induced E2A Degradation Requires CHIP and Hsc70 as Novel Facilitators of Ubiquitination Mol. Cell. Biol., October 15, 2004; 24(20): 8951 - 8962. [Abstract] [Full Text] [PDF]

				T. M. Schlaeger, A. Schuh, S. Flitter, A. Fisher, H. Mikkola, S. H. Orkin, P. Vyas, and C. Porcher Decoding Hematopoietic Specificity in the Helix-Loop-Helix Domain of the Transcription Factor SCL/Tal-1 Mol. Cell. Biol., September 1, 2004; 24(17): 7491 - 7502. [Abstract] [Full Text] [PDF]

				M. Tremblay, S. Herblot, E. Lecuyer, and T. Hoang Regulation of pTalpha Gene Expression by a Dosage of E2A, HEB, and SCL J. Biol. Chem., April 4, 2003; 278(15): 12680 - 12687. [Abstract] [Full Text] [PDF]

				I. Engel and C. Murre Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice PNAS, August 20, 2002; 99(17): 11322 - 11327. [Abstract] [Full Text] [PDF]

				N. Goardon, A. Schuh, I. Hajar, X. Ma, H. Jouault, E. Dzierzak, P.-H. Romeo, and L. Maouche-Chretien Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation Blood, June 28, 2002; 100(2): 491 - 500. [Abstract] [Full Text] [PDF]

				S. Herblot, P. D. Aplan, and T. Hoang Gradient of E2A Activity in B-Cell Development Mol. Cell. Biol., February 1, 2002; 22(3): 886 - 900. [Abstract] [Full Text] [PDF]

				F. J.T. Staal, F. Weerkamp, A. W. Langerak, R. W. Hendriks, and H. C. Clevers Transcriptional Control of T Lymphocyte Differentiation Stem Cells, May 1, 2001; 19(3): 165 - 179. [Abstract] [Full Text]

				B. J. Feldman, T. Hampton, and M. L. Cleary A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice Blood, September 1, 2000; 96(5): 1906 - 1913. [Abstract] [Full Text] [PDF]

				R. Bayly and D. P. LeBrun Role for Homodimerization in Growth Deregulation by E2a Fusion Proteins Mol. Cell. Biol., August 15, 2000; 20(16): 5789 - 5796. [Abstract] [Full Text]

				J. Wang, S. N. Jani-Sait, E. A. Escalon, A. J. Carroll, P. J. de Jong, I. R. Kirsch, and P. D. Aplan The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene PNAS, March 28, 2000; 97(7): 3497 - 3502. [Abstract] [Full Text] [PDF]

				S. Huang and S. J. Brandt mSin3A Regulates Murine Erythroleukemia Cell Differentiation through Association with the TAL1 (or SCL) Transcription Factor Mol. Cell. Biol., March 15, 2000; 20(6): 2248 - 2259. [Abstract] [Full Text]

				A. Pagliuca Cancer Res., March 1, 2000; 60(5): 1376 - 1382.

				M. E. Massari and C. Murre Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms Mol. Cell. Biol., January 15, 2000; 20(2): 429 - 440. [Full Text]

				C. Courtes, N. Lecointe, L. Le Cam, F. Baudoin, C. Sardet, and D. Mathieu-Mahul Erythroid-specific Inhibition of the tal-1 Intragenic Promoter Is Due to Binding of a Repressor to a Novel Silencer J. Biol. Chem., January 14, 2000; 275(2): 949 - 958. [Abstract] [Full Text] [PDF]

				D. S. Chervinsky, X.-F. Zhao, D. H. Lam, M. Ellsworth, K. W. Gross, and P. D. Aplan Disordered T-Cell Development and T-Cell Malignancies in SCL LMO1 Double-Transgenic Mice: Parallels with E2A-Deficient Mice Mol. Cell. Biol., July 1, 1999; 19(7): 5025 - 5035. [Abstract] [Full Text] [PDF]

				C. G. Begley and A. R. Green The SCL Gene: From Case Report to Critical Hematopoietic Regulator Blood, May 1, 1999; 93(9): 2760 - 2770. [Full Text] [PDF]

				I. Engel and C. Murre Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas PNAS, February 2, 1999; 96(3): 996 - 1001. [Abstract] [Full Text] [PDF]

				S. T. Park, G. P. Nolan, and X.-H. Sun Growth Inhibition and Apoptosis Due to Restoration of E2A Activity in T Cell Acute Lymphoblastic Leukemia Cells J. Exp. Med., February 1, 1999; 189(3): 501 - 508. [Abstract] [Full Text] [PDF]